Entrada Therapeutics Inc's total assets for Q2 2025 were $448.78M, a decrease of -7.75% from the previous quarter. TRDA total liabilities were $69.28M for the fiscal quarter, a 0.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.